Related Experiment Video
Updated: May 7, 2026
05:36
Author Spotlight: Advancing Gene Silencing Research in Silkworms with dsRNA Delivery Through Feeding Chitosan Nanoparticles
Published on: October 4, 2024
2.2K
Tebufenozide disrupts ovarian development and function in silkmoths
1Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Insect Biochemistry and Molecular Biology
|October 15, 2013
Summary
Tebufenozide, a non-steroidal ecdysteroid agonist, hinders silkmoth ovarian development and egg production by disrupting follicular tissues and inhibiting vitellogenin uptake. This suggests dual inhibitory mechanisms are involved in its effects on oogenesis.
Area of Science:
- Insect endocrinology
- Developmental biology
- Reproductive physiology
Background:
- 20-hydroxyecdysone (20E) is crucial for adult silkmoth development and egg production.
- Tebufenozide is a non-steroidal ecdysteroid agonist used to study hormonal effects.
Purpose of the Study:
- To investigate the effects of tebufenozide on silkmoth ovarian development and egg formation.
- To elucidate the mechanisms underlying tebufenozide's impact on oogenesis.
Main Methods:
- Administering tebufenozide to female silkmoth pharate adults.
- Assessing epidermal tissue development, ovarian growth, and egg formation.
- Analyzing RNA and protein synthesis, vitellogenin (Vg) accumulation in ovaries and hemolymph.
- Measuring hemolymph volumes.
Main Results:
- Tebufenozide induced full epidermal development but minimal ovarian growth and egg formation.
- Disruption of follicular epithelium, nurse cell damage, and inhibited oogenesis were observed.
- Reduced RNA/protein synthesis and vitellogenin uptake in ovaries occurred.
- Hemolymph vitellogenin levels remained constant, suggesting egg development involves uptake of multiple hemolymph proteins.
Conclusions:
- Tebufenozide exhibits biphasic inhibitory actions on silkmoth ovaries through dual mechanisms.
- These mechanisms involve ecdysteroid antagonist action and another function during egg formation.
- 20E cannot overcome the ovarian growth inhibitory effects of tebufenozide.
Related Concept Videos
02:07Oogenesis
58.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
58.5K
01:15Drugs that Stabilize Microtubules
2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
01:07Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K